Information Journal Paper
APA:
Copy. (2019). Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE). INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 77(-), 105-123. SID. https://sid.ir/paper/779700/en
Vancouver:
Copy. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE). INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY[Internet]. 2019;77(-):105-123. Available from: https://sid.ir/paper/779700/en
IEEE:
Copy, “Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE),” INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, vol. 77, no. -, pp. 105–123, 2019, [Online]. Available: https://sid.ir/paper/779700/en